{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T14:05:14Z","timestamp":1784642714532,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T00:00:00Z","timestamp":1675468800000},"content-version":"am","delay-in-days":309,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.ejogrb.2022.01.026","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T17:52:19Z","timestamp":1643737939000},"page":"7-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Identification of patients with ductal carcinoma in situ at high risk of postoperative upstaging: A comprehensive review and an external (un)validation of predictive models developed"],"prefix":"10.1016","volume":"271","author":[{"given":"Marjolaine","family":"Le Gac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohann","family":"Dabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ilenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiphaine","family":"De Foucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"Ferrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Zilberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Sussfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Touboul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emile","family":"Dara\u00ef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofiane","family":"Bendifallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejogrb.2022.01.026_b0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.01.026_b0010","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10549-014-3073-9","article-title":"Trends in breast cancer incidence and mortality in France 1990\u20132008","volume":"147","author":"Molini\u00e9","year":"2014","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.ejogrb.2022.01.026_b0015","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s12253-008-9054-8","article-title":"Microinvasive carcinoma of the breast","volume":"14","author":"Bianchi","year":"2008","journal-title":"Pathol Oncol Res"},{"issue":"2","key":"10.1016\/j.ejogrb.2022.01.026_b0020","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/SLA.0b013e31815b446b","article-title":"Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European Institute of Oncology on 854 patients in 10 years","volume":"247","author":"Intra","year":"2008","journal-title":"Ann Surg"},{"issue":"12","key":"10.1016\/j.ejogrb.2022.01.026_b0025","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1245\/s10434-015-4476-5","article-title":"The role of sentinel lymph node biopsy and factors associated with invasion in extensive DCIS of the breast treated by mastectomy: the Cinnamome prospective multicenter study","volume":"22","author":"Tunon-de-Lara","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejogrb.2022.01.026_b0030","doi-asserted-by":"crossref","first-page":"258","DOI":"10.5306\/wjco.v7.i2.258","article-title":"Sentinel lymph node biopsy in clinically detected ductal carcinoma in situ","volume":"7","author":"Al-Ameer","year":"2016","journal-title":"World J Clin Oncol"},{"issue":"10","key":"10.1016\/j.ejogrb.2022.01.026_b0035","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1245\/s10434-017-5927-y","article-title":"A validated nomogram to predict upstaging of ductal carcinoma in situ to invasive disease","volume":"24","author":"Jakub","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejogrb.2022.01.026_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/480840","article-title":"A simple model to assess the probability of invasion in ductal carcinoma in situ of the breast diagnosed by needle biopsy","volume":"2014","author":"Coufal","year":"2014","journal-title":"BioMed Res Int"},{"issue":"5","key":"10.1016\/j.ejogrb.2022.01.026_b0045","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.breast.2013.03.009","article-title":"A nomogram for predicting underestimation of invasiveness in ductal carcinoma in situ diagnosed by preoperative needle biopsy","volume":"22","author":"Park","year":"2013","journal-title":"Breast"},{"issue":"5","key":"10.1016\/j.ejogrb.2022.01.026_b0050","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/jso.24037","article-title":"A model to predict upstaging to invasive carcinoma in patients preoperatively diagnosed with ductal carcinoma in situ of the breast","volume":"112","author":"Kondo","year":"2015","journal-title":"J Surg Oncol"},{"issue":"13","key":"10.1016\/j.ejogrb.2022.01.026_b0055","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1245\/s10434-019-07750-9","article-title":"A nomogram to predict factors associated with lymph node metastasis in ductal carcinoma in situ with microinvasion","volume":"26","author":"Gooch","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejogrb.2022.01.026_b0060","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1245\/s10434-010-1438-9","article-title":"Accuracy of a preoperative model for predicting invasive breast cancer in women with ductal carcinoma-in-situ on vacuum-assisted core needle biopsy","volume":"18","author":"Houssami","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.ejogrb.2022.01.026_b0065","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3349\/ymj.2019.60.11.1028","article-title":"An updated nomogram for predicting invasiveness in preoperative ductal carcinoma in situ of the breast","volume":"60","author":"Kim","year":"2019","journal-title":"Yonsei Med J"},{"issue":"5","key":"10.1016\/j.ejogrb.2022.01.026_b0070","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/jmri.25655","article-title":"Can algorithmically assessed MRI features predict which patients with a preoperative diagnosis of ductal carcinoma in situ are upstaged to invasive breast cancer?","volume":"46","author":"Harowicz","year":"2017","journal-title":"J Magn Reson Imaging"},{"issue":"10","key":"10.1016\/j.ejogrb.2022.01.026_b0075","doi-asserted-by":"crossref","first-page":"e77826","DOI":"10.1371\/journal.pone.0077826","article-title":"Development and evaluation of a prediction model for underestimated invasive breast cancer in women with ductal carcinoma in situ at stereotactic large core needle biopsy","volume":"8","author":"Diepstraten","year":"2013","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.01.026_b0080","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1148\/radiol.11102368","article-title":"Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer","volume":"260","author":"Brennan","year":"2011","journal-title":"Radiology"},{"issue":"13","key":"10.1016\/j.ejogrb.2022.01.026_b0085","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/bjs.9337","article-title":"Nomogram for predicting invasion in patients with a preoperative diagnosis of ductal carcinoma in situ of the breast","volume":"100","author":"Lee","year":"2013","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejogrb.2022.01.026_b0090","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.breast.2012.11.002","article-title":"Prediction of underestimated invasiveness in patients with ductal carcinoma in situ of the breast on percutaneous biopsy as rationale for recommending concurrent sentinel lymph node biopsy","volume":"22","author":"Schulz","year":"2013","journal-title":"Breast"},{"issue":"4","key":"10.1016\/j.ejogrb.2022.01.026_b0095","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jamcollsurg.2004.11.012","article-title":"Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ","volume":"200","author":"Yen","year":"2005","journal-title":"J Am Coll Surg"},{"issue":"9","key":"10.1016\/j.ejogrb.2022.01.026_b0100","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/s41416-018-0276-6","article-title":"A prediction model for underestimation of invasive breast cancer after a biopsy diagnosis of ductal carcinoma in situ: based on 2892 biopsies and 589 invasive cancers","volume":"119","author":"Meurs","year":"2018","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.ejogrb.2022.01.026_b0105","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.breast.2012.06.009","article-title":"Predictors of invasive breast cancer and lymph node involvement in ductal carcinoma in situ initially diagnosed by vacuum-assisted breast biopsy: experience of 733 cases","volume":"21","author":"Trentin","year":"2012","journal-title":"Breast"},{"key":"10.1016\/j.ejogrb.2022.01.026_b0110","doi-asserted-by":"crossref","unstructured":"Cutuli B, Tunon De Lara C, Arnaud A, et al. [Ductal carcinoma in situ diagnosis: 3French national guidelines]. Ann Pathol 2016;36:166\u201373.","DOI":"10.1016\/j.annpat.2016.03.012"},{"issue":"4","key":"10.1016\/j.ejogrb.2022.01.026_b0115","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/jnci\/djn010","article-title":"Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study","volume":"100","author":"Partridge","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejogrb.2022.01.026_b0120","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejca.2016.09.035","article-title":"Patient-reported outcomes in ductal carcinoma in situ: a systematic review","volume":"71","author":"King","year":"2017","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.ejogrb.2022.01.026_b0125","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1524-4741.2011.01069.x","article-title":"Predictors of invasion and axillary lymph node metastasis in patients with a core biopsy diagnosis of ductal carcinoma in situ: an analysis of 255 cases","volume":"17","author":"Han","year":"2011","journal-title":"Breast J"},{"issue":"4","key":"10.1016\/j.ejogrb.2022.01.026_b0130","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3390\/cancers13040868","article-title":"Complete removal of the lesion as a guidance in the management of patients with breast ductal carcinoma in situ","volume":"13","author":"Nicosia","year":"2021","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.ejogrb.2022.01.026_b0135","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.3390\/diagnostics11061120","article-title":"Atypical ductal hyperplasia after vacuum-assisted breast biopsy: can we reduce the upgrade to breast cancer to an acceptable rate?","volume":"11","author":"Nicosia","year":"2021","journal-title":"Diagnostics"},{"issue":"12","key":"10.1016\/j.ejogrb.2022.01.026_b0140","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.ejso.2013.09.028","article-title":"Concordance between vacuum assisted biopsy and postoperative histology: implications for the proposed Low Risk DCIS Trial (LORIS)","volume":"39","author":"Soumian","year":"2013","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"10.1016\/j.ejogrb.2022.01.026_b0145","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1245\/s10434-017-6018-9","article-title":"Surgical upstaging rates for vacuum assisted biopsy proven DCIS: implications for active surveillance trials","volume":"24","author":"Grimm","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"13","key":"10.1016\/j.ejogrb.2022.01.026_b0150","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1245\/s10434-016-5595-3","article-title":"Women with low-risk DCIS eligible for the LORIS trial after complete surgical excision: how low is their risk after standard therapy?","volume":"23","author":"Pilewskie","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.ejogrb.2022.01.026_b0155","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/bjs.5735","article-title":"Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy","volume":"94","author":"Meijnen","year":"2007","journal-title":"Br J Surg"},{"issue":"8","key":"10.1016\/j.ejogrb.2022.01.026_b0160","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1002\/cncr.22216","article-title":"Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ","volume":"107","author":"Huo","year":"2006","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2022.01.026_b0165","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1148\/radiology.218.2.r01fe35497","article-title":"Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates","volume":"218","author":"Jackman","year":"2001","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.ejogrb.2022.01.026_b0170","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10549-006-9167-2","article-title":"Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ? Analysis of 587 cases","volume":"98","author":"Goyal","year":"2006","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"10.1016\/j.ejogrb.2022.01.026_b0175","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1007\/s00330-012-2394-5","article-title":"MRI of the breast in patients with DCIS to exclude the presence of invasive disease","volume":"22","author":"Deurloo","year":"2012","journal-title":"Eur Radiol"},{"issue":"6","key":"10.1016\/j.ejogrb.2022.01.026_b0180","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/jjco\/hyt055","article-title":"The clinical significance of breast MRI in the management of ductal carcinoma in situ diagnosed on needle biopsy","volume":"43","author":"Miyashita","year":"2013","journal-title":"Jpn J Clin Oncol"},{"issue":"15_suppl","key":"10.1016\/j.ejogrb.2022.01.026_b0185","doi-asserted-by":"crossref","first-page":"TPS603","DOI":"10.1200\/JCO.2019.37.15_suppl.TPS603","article-title":"The international collaboration of active surveillance trials for low-risk DCIS (LORIS, LORD, COMET, LORETTA).","volume":"37","author":"Kanbayashi","year":"2019","journal-title":"JCO"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.01.026_b0190","doi-asserted-by":"crossref","DOI":"10.1186\/bcr2464","article-title":"PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer","volume":"12","author":"Wishart","year":"2010","journal-title":"Breast Cancer Res"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.01.026_b0195","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10549-016-3804-1","article-title":"Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer","volume":"157","author":"Green","year":"2016","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"10.1016\/j.ejogrb.2022.01.026_b0200","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1200\/JCO.1999.17.5.1499","article-title":"Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer","volume":"17","author":"Kattan","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejogrb.2022.01.026_b0205","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.sla.0000133125.85489.07","article-title":"Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas","volume":"240","author":"Brennan","year":"2004","journal-title":"Ann Surg"},{"issue":"28","key":"10.1016\/j.ejogrb.2022.01.026_b0210","doi-asserted-by":"crossref","first-page":"7005","DOI":"10.1200\/JCO.2005.01.867","article-title":"Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy","volume":"23","author":"Stephenson","year":"2005","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejogrb.2022.01.026_b0215","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1200\/JCO.2007.14.1291","article-title":"Individualized prediction of colon cancer recurrence using a nomogram","volume":"26","author":"Weiser","year":"2008","journal-title":"J Clin Oncol"},{"issue":"23","key":"10.1016\/j.ejogrb.2022.01.026_b0220","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1200\/JCO.2009.26.8847","article-title":"Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ","volume":"28","author":"Rudloff","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejogrb.2022.01.026_b0225","doi-asserted-by":"crossref","first-page":"232","DOI":"10.7150\/jca.2.232","article-title":"Biological markers in DCIS and risk of breast recurrence: a systematic review","volume":"2","author":"Lari","year":"2011","journal-title":"J Cancer"},{"issue":"6","key":"10.1016\/j.ejogrb.2022.01.026_b0230","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.pathol.2019.07.005","article-title":"Ductal carcinoma in situ of breast: update 2019","volume":"51","author":"Badve","year":"2019","journal-title":"Pathology"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211522000331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211522000331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T13:51:39Z","timestamp":1784641899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211522000331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":46,"alternative-id":["S0301211522000331"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2022.01.026","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of patients with ductal carcinoma in situ at high risk of postoperative upstaging: A comprehensive review and an external (un)validation of predictive models developed","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2022.01.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}